Stacey Tinianov: How Can New Strategies Transform Preclinical and Early-Phase Clinical Development?
Stacey Tinianov/LinkedIn

Stacey Tinianov: How Can New Strategies Transform Preclinical and Early-Phase Clinical Development?

Stacey Tinianov, Founder, Executive Director at Advocates for Collaborative Education, shared on LinkedIn:

“Grateful to meet the members of the Friends of Cancer Research working groups in person and share some space with a few Advocates for Collaborative Education members last night at the Friends of Cancer Research reception, in advance of today’s Annual Meeting.

Looking forward to the discussions with industry, FDA, and advocacy around the newly released white papers on responsible acceleration of clinical development including pre-clinical development, first-in-human studies, and model-informed dosing optimization.”

Other articles about Stacey Tinianov on OncoDaily.